TISSUEGENE INC has a total of 86 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2000. It filed its patents most often in Republic of Korea, China and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are BAVARIAN NORDIC A, JENNEREX INC and KOLON TISSUEGENE INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 13 | |
#2 | China | 12 | |
#3 | Canada | 11 | |
#4 | EPO (European Patent Office) | 11 | |
#5 | Japan | 10 | |
#6 | WIPO (World Intellectual Property Organization) | 9 | |
#7 | Australia | 8 | |
#8 | United States | 8 | |
#9 | Hungary | 2 | |
#10 | Singapore | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Measurement | |
#5 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Object sterilising | |
#6 | Enzymes | |
#7 | Analysing materials | |
#8 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Lee Kwan Hee | 77 |
#2 | Noh Moon Jong | 65 |
#3 | Yi Youngsuk | 38 |
#4 | Song Sun Uk | 19 |
#5 | Bae Hyun | 17 |
#6 | Lee Duk Keun | 11 |
#7 | Kim Hyoung Chun | 10 |
#8 | Kang Sung Woo | 10 |
#9 | Kang Kyoung Ae | 8 |
#10 | Yi Young Suk | 8 |
Publication | Filing date | Title |
---|---|---|
AU2015203016A1 | Treatment of intervertebral disc degeneration | |
CN105873942A | Treatment of damaged nerve with PTEN inhibitor | |
KR20140136061A | Primed cell therapy | |
KR20110036696A | Treatment of intervertebral disc degeneration | |
CA2735272A1 | Nerve regeneration by transplanting cells expressing recombinant transforming growth factor superfamily protein | |
US2006019396A1 | Retroviral vectors with enhanced efficiency of transgene expression and safety | |
AU2003218463A1 | Bone generation by gene therapy | |
CN1653179A | Cartilage regeneration using chondrocyte and TGF-beta | |
US7431922B2 | Bioadhesive directed somatic cell therapy | |
US7005127B2 | Mixed-cell gene therapy | |
WO02055656A2 | GENE THERAPY USING TGF-$g(b) | |
US7338655B1 | Gene therapy using TGF-β | |
US6797703B1 | Gene therapy using TGF-β |